AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05073380 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Wait List Group - Normal Daily Practice
Description: ELCCs that are randomly assigned to the waitlist group will participate in their normal daily practice, including standard curriculum and outdoor play time. Once post-data collection is complete, wait list sites will be given the PRO-ECO intervention.
Study NCT06009926 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Training
Description: Undergo flashover training
Study NCT06184581 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lamotrigine
Description: The trial is designed as a single-blinded two-armed, parallel randomized trial with randomization 1:1 to lamotrigine versus lithium.
Study NCT04854460 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Revemact
Description: 1 tablet contains 6 mg Ivermecin
Study NCT04854460 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Stromectol (first dose)
Description: 2 tablet contain 6 mg Ivermecin
Study NCT04854460 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Stromectol (second dose)
Description: 2 tablet contain 6 mg Ivermecin
Study NCT06149767 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab
Description: The medication regimen for all enrolled patients is as follows, and the dose can be adjusted during treatment due to adverse reactions and other circumstances:~Adebrelimab : 20 mg/kg, D1, intravenously, 30-60 min, Q3w. Paclitaxel for Injection: 150 mg/m2, D1 Cisplatin: 50 mg/m2, IV, D1, Q3w. Radiotherapy: pelvic dose: 6MV-X, 180cGy/ times 27 times; Brachydose: 192Ir, 700cGy/ time 4 times.~First of all, after 2 cycles of concurrent chemoradiotherapy, the sequential chemotherapy combined with adbalizumab for 2-4 cycles, and the subsequent investigators selected Adbalizumab or other drugs to maintain the treatment according to the patient's situation or the patient's own will until the disease progressed or intolerable toxicity occurred or the subjects voluntarily withdrew from the study.adebrelimab until disease progression or intolerable toxicity or the subject voluntarily withdrew from the study。
Study NCT05675020 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Zoom Intervention
Description: This educational program will be delivered via a 45-minute presentation via Zoom.~* The educational presentation will be recorded and emailed to participants within 1 week of intervention to re-watch/review.~* The educational program will promote a healthy lifestyle knowledge and behaviors through education evidenced by the CDC, WHO, and the American Academy of Pediatrics. Educational sessions will include the importance of healthy lifestyle modifications in the adolescent population with a mental health condition(s), lifestyle recommendations versus reality, nutrition, physical activity, screen time, and sleep recommendations and guidelines.~* We will compare the effects of an educational program on healthy lifestyle knowledge and behaviors pre-and post-program (after one month) via a REDCap survey for the adolescent and their parent/legal guardian.
Study NCT06309329 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Strength at Home Parents
Description: Strength at Home parents is an 8 week trauma-informed and cognitive behavioral tele-health group intervention that aims to improve parenting behaviors and overall parent-child and family functioning among U.S. military Veterans with post-traumatic stress disorder symptoms
Study NCT06309329 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: VA treatment as usual
Description: VA treatment as usual includes referral to the online resources at veterantraining.va.gov/parenting .
Study NCT05998928 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine + Cyclophosphamide + BCMA-GPRC5D CAR-T Cells
Description: fludarabine 30 mg/m2 and cyclophosphamide 300 mg/m2 both on three consecutive days during D-7 to D-3~BCMA-GPRC5D CAR-T Cells on day 0
Study NCT05072470 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Roger microphone
Description: Commercially available transmitter microphone which sends distant speech signals to a receiver that is attached/embedded into hearing aids.
Study NCT05072470 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Phonak Audeo hearing aid
Description: Commercially available receiver-in-canal hearing aid
Study NCT05503121 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: 3D motion analysis, muscle activation, biomarker analysis
Description: Participants with nonspesific low back pain and control group will be analysed with 3D motion analysis sistem, sEMG and will be checked the biomarkers. Then the data will be compared.
Study NCT05196178 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation
Description: Paddle-shaped Spinal cord stimulation electrode with 16 contacts (AdaptiveStim® 39, 565;Medtronic, USA) will be implanted into the epidural space at the thoracic levels ranging from T10 to T12.
Study NCT05895799 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Tuition from a expert clinical trainer
Description: Each group was initially provided with an online tutorial on the complete physical examination of the cardiovascular system as performed on a standardized patient by the trainer. At the beginning of each session, the trainer performed the examination on a hybrid patient wearing the auscultation vest and provided additional teaching, explanations, and rationale. Following the demonstration, each participant was invited to perform repeated physical examinations in front of their peers with real-time one-to-one feedback from the trainer. After each performance, the participant was encouraged to critique their own performance(s), peers were invited to provide some insights, and the trainer gave some overall feedback. At the end of the session and after each participant had had the opportunity to perform the complete examination at least once, the participants were taken through a range of abnormal signs using the auscultation vest with explanations provided by the trainer.
Study NCT05919212 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: HER2-D is the use of a non-invasive liquid biopsy method to non-invasively and objectively assess HER2 status at recruitment
Description: We study the circulating changes associated with resistance to T-DXd, including changes in HER2 status,studied through a new approach called HER2-2D that simultaneously assesses HER2 amplification and overexpression in blood
Study NCT06085391 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: REThink Game
Description: REThink Game is the therapeutic game that uses psychological science to help youths find their superhero emotional strengths! It is composed of seven levels, each training a specific emotion regulation ability: emotion recognition, mindfulness and relaxation, cognitive change, positive bias, distinction between useful and useless thoughts, problem solving and compassion.
Study NCT06300905 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: test product
Description: toothpaste containing 0.45% stannous fluoride
Study NCT06300905 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: test product
Description: toothpaste containing 0.45% stannous fluoride
Study NCT06085391 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: MoodWheel
Description: Mood Wheel is a web and mobile-based app that uses experience sampling procedures for the assessment of current/previous distress and positive emotions. The aim of the app is to inquire about the valence, control and functionality of users' emotions.
Study NCT06085391 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PsyPills
Description: PsyPills is a self-help psycho-educational instrument intended to build stress resilience and to target (only) mild and transient negative mood states, alone or in combination with other methods/instruments.~Psychological Pills (PsyPills) are inspired by Rational-Emotive \& Cognitive-Behavioral Therapy (CBT/REBT), which has strong evidence for its efficacy/effectiveness in human development/health promotion and in the treatment of a variety of psychological conditions.~The PsyPills app was tested in a pilot study and showed positive effects on reducing distress.
Study NCT06300905 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Control product
Description: toothpaste containing 0.76% sodium monofluorophosphate
Study NCT06300905 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Control product
Description: toothpaste containing 0.76% sodium monofluorophosphate
Study NCT06230055 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ommaya reservoir
Description: Intrathecal chemotherapy through Ommaya reservoir
Study NCT06230055 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Systematic chemotherapy
Description: Systematic chemotherapy: including capecitabine(1000mg/m2 bid, d1-14, q3w, po), gemcitabine(1000mg/m2, d1,8, q3w, ivgtt), vinorelbine(25mg/m2, d1,8, q3w, ivgtt), docetaxel(75mg/m2, d1, q3w, ivgtt),Nab-paclitaxel(125mg/m2, d1,8, q3w, ivgtt), or iribrin(1.4mg/m2, d1,8, q3w, iv).
Study NCT06230055 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Systematic chemotherapy
Description: Systematic chemotherapy: including capecitabine(1000mg/m2 bid, d1-14, q3w, po), gemcitabine(1000mg/m2, d1,8, q3w, ivgtt), vinorelbine(25mg/m2, d1,8, q3w, ivgtt), docetaxel(75mg/m2, d1, q3w, ivgtt),Nab-paclitaxel(125mg/m2, d1,8, q3w, ivgtt), or iribrin(1.4mg/m2, d1,8, q3w, iv).
Study NCT05609422 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physical therapy program
Description: * Stretching exercises~* Strength Training Kneeling exercises~* Standing exercises~* Gait Training
Study NCT05609422 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical therapy program
Description: * Stretching exercises~* Strength Training Kneeling exercises~* Standing exercises~* Gait Training
Study NCT05609422 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: scooter board activities
Description: 1. Scooter board bear walk.~2. Scooter board crab walk.~3. Sitting on scooter board, use it to move forward and backward, move the pool rings from one end to another.~4. Cross sitting on scooter board, pulls along the rope using his/her hands~5. Sit with knees pulled into the chest (like a bug pose) and move around with arms only.~6. Prone over scooter board, pulling rope to move forward. Pull self along an anchored rope to retrieve items~7. Scooter rolls outs. Place knees on floor and hands holding the edge of the front scooter board. Push board out a few inches then pull back, the further you roll, the harder it gets.~8. Kneeling, Push self forward and backward with the use of a therapy ball (lots of Motor Planning).~9. Supine flexion on scooter board, Clip clothespins to a rope hanging above.
Study NCT06511609 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: double-flap technique（DFT）; double-tract reconstruction(DTR),
Description: DFT (experiment group). Patients receive double flap technique after laparoscopic proximal gastrectomy. DTR (control group). Patients receive double-tract reconstruction after laparoscopic proximal gastrectomy.
Study NCT06511609 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: double-flap technique（DFT）; double-tract reconstruction(DTR),
Description: DFT (experiment group). Patients receive double flap technique after laparoscopic proximal gastrectomy. DTR (control group). Patients receive double-tract reconstruction after laparoscopic proximal gastrectomy.
Study NCT05333562 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Motor control exercise
Description: Motor control exercise was given with total of 8 sessions for 30 min for 4 weeks twice a day. Each exercise was performed 10 repetitions for 10 sec.
Study NCT05333562 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Motor control exercise with mobilization
Description: this was given motor control exercise for 30 min, 4 weeks twice a day plus neural gliding applied for 3 sets of 10 repetitions on each session. Neural gliding applied 5 min before motor control exercise. Total 8 sessions were given
Study NCT05400941 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Practice Led Intervention
Description: This is a quality improvement intervention that includes learning collaboratives, practice facilitation, expert consultation and audit and feedback.
Study NCT05457530 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: DOR/3TC/TDF
Description: 100 mg of doravirine (DOR), 300 mg of lamivudine (3TC), and 300 mg of TDF
Study NCT05457530 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: DOR + FTC/TAF
Description: 100 mg of doravirine + 200 mg emtricitabine (FTC) and 25 mg of tenofovir alefenamide fumerate (TAF)
Study NCT05457530 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BIC/FTC/TAF
Description: Bictegravir sodium 50 mg, emtricitabine 200mg, tenofovir alefenamide fumerate 25mg
Study NCT05652192 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: SBRT
Description: SBRT was added to systematic treatment (chemo+ PD-1 antibody)
Study NCT05668650 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pembrolizumab
Description: Study drug administration: intravenous infusion Dosing instructions: 200 mg administered over 30 minutes, every 3 weeks The time for infusion should be closer to 30 minutes. However, considering the variability of the infusion pumps from one center to another, a -5 to +10 minutes window is allowed (ie, the time for infusion is 30 minutes with an allowed range of 25 to 40 minutes).
Study NCT05668650 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab biosimilar
Description: Study drug administration: intravenous infusion Dosing instructions: 200 mg administered over 30 minutes, every 3 weeks The time for infusion should be closer to 30 minutes. However, considering the variability of the infusion pumps from one center to another, a -5 to +10 minutes window is allowed (ie, the time for infusion is 30 minutes with an allowed range of 25 to 40 minutes).
Study NCT06130384 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Use of bromfenac 0.09% to reduce intravitreal injection pain
Description: The eyedrop (bromfenac) will be given to the assigned eye.
Study NCT06130384 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Use of artificial tears to reduce intravitreal injection pain
Description: The eyedrop (artificial tears) will be given to the assigned eye.
Study NCT04876001 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief Behavior Therapy for Insomnia
Description: The BBTI consists of two in-person sessions on week 1 and 3 and two sessions on week 2 and 4 as the booster delivered by phone call.
Study NCT05693623 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: cold application
Description: cold application
Study NCT05322460 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CUMACA-M Program
Description: The CUMACA-M Program will focus on a web-based tailored intervention, using artificial intelligence, for Long-Term Survivors of Breast Cancer. It will be structured into modules related to the specific needs of LS-BS, including physical, psychological, and social needs
Study NCT05762822 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: 3-OHB (KE4)
Description: 60 ml (30 g) of 3-OHB
Study NCT05762822 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: water
Description: 60 ml water (added bitter taste)
Study NCT06563388 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Stereotactic Ablative Radiotherapy
Description: Radiation therapy begins after 3 months of Standard of care
Study NCT06563388 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Best Practice
Description: Receive standard of care therapy
Study NCT04759911 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT04759911 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT04759911 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selpercatinib
Description: Given PO
Study NCT04759911 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Therapeutic Conventional Surgery
Description: Undergo standard of care surgery
Study NCT06366555 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Manual Acupuncture Twirling,
Description: Manual Acupuncture twirling : using 0.14x 25 mm needle, punctured and penetrated the skin and then a twirling manipulation is carried out, 180 degrees, 3 rad/second, for 30 second each at LU5 and PC2. The needles retained for 20 minutes and manipulated at 0 minutes and 10 minutes.
Study NCT06366555 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Manual Acupuncture Sham
Description: Manual Acupuncture Sham : Using 0.14x25mm needles on plesterin without being penetrated into skin and no manipulation given, retained for 20 minutes
Study NCT06182449 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality Distraction
Description: In a private NICU room, mothers will wear a head-mounted VR device when they will initiate the expression of their maternal milk. The video within the VR system will provide a calm forest environment with waterfalls, animals, and birdsong (INSPIRE® Program). The baby may or may not be present in the room during the intervention. This will be documented.
Study NCT06182449 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Protocol
Description: Mothers will express their maternal milk in a private room in the NICU with their baby or a photo of the baby. Use of any co-interventions for anxiety management (e.g. music) durign this sequence will be documented.
Study NCT06253260 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Analgesic Efficacy of Sequential Rapid Intrathecal Injection Of Dexmedetomidine Followed by Slow Injection of Hyperbaric Bupivacaine Injection in Patients Undergoing Unilateral Inguinal Hernia Repair
Description: Analgesic Efficacy of Sequential Rapid Intrathecal Injection Of Dexmedetomidine Followed by Slow Injection of Hyperbaric Bupivacaine Injection in Patients Undergoing Unilateral Inguinal Hernia Repair Surgery
Study NCT05398874 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Ginkgo biloba extract + standard treatment( paracetamol+Diclofenac100mg SR)
Description: 120 mg leaf extract , twice daily in addition to Diclofenac 100 mg Once daily + paracetamol 1g Twice daily
Study NCT05398874 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: placebo in addition to the standard treatment
Description: placebo in addition to the standard treatment
Study NCT05887856 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: comprehensive educational program for reduction of Pre-Operative Anxiety
Description: BSEP 1 makes use of modern media and aims to educate patients and their carers through educational videos comprising of various aspect of surgical treatment.~1. Introduction to surgery by consultant surgeon, Patient to receive video of their own surgeon.~2. Introduction to Anesthesia.~3. What are different type of breast surgeries in cancer patients (General Video)~4. Specific video pertaining to the type of surgery patient is undergoing (Mastectomy, Breast Conserving Surgery, Breast Re Construction surgery)~5. Explanation of Methicillin-resistant Staphylococcus aureus Decolonization protocol~6. What to expect on Surgery Day~7. Virtual tour of Holding bay and Operation Room~8. Post-Operative care including wound care, drain management and common post-operative complications.
Study NCT04706598 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camrelizumab
Description: Solution for Infusion (Intravesical)
Study NCT05082870 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Supportive-expressive group therapy (SEGT)
Description: The SEGT approach fosters mutual support, promotes openness and emotional expression. SEGT will be delivered and co-facilitated by a psychiatrist and an allied healthcare professional. It is a 6-module program held over a 3-week period (approximately 2 hour sessions X 2 week) that is framed within social cognitive theory, whereby resilience to adversity (limb loss in this instance) relies on personal enablement.
Study NCT04847830 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Er:YAG laser (Waterlase)
Description: The WaterLase iPlus tissue cutting system is a unique device with diverse, hard- and soft-tissue dental applications. It utilizes advanced laser and water atomization technologies to safely and effectively cut, shave, contour, roughen, etch, and resect oral hard-tissue, and direct laser energy to perform oral soft-tissue removal, incision, excision, ablation and coagulation.
Study NCT04847830 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: root surface dbridement
Description: root surface debridement under local anaesthesia
Study NCT04847830 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: root surface dbridement
Description: root surface debridement under local anaesthesia
Study NCT05125042 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Amiodarone hydrochloride tablet + acupoint catgut embedding
Description: Patients with persistent AF after undergoing catheter ablation take receive acupoint catgut embedding in Neiguan and Zusanli twice after and one month after surgery combined with amiodarone hydrochloride tablets 200mg bid, 1 month; 200mg qd,maintained to 3 months.All patients, who had no signs of recurrence three months after surgery, stopped taking medication.
Study NCT05569577 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Additional hCG injection
Description: An additional hCG injection of 2000-5000IU would be given 48 hours following routine hCG trigger and ovulation for LPS on the basis of supplementation of estrogen and dydrogesterone.